Finding may make islet cell transplantation a more viable therapy for Type 1 diabetes.
Read how Frederick Banting and his team essentially gave away the patent for insulin to help humanity.
A British pharmaceutical firm is fined for its role in the 2010 death of a man on insulin therapy.
An explanation of how the agency allocates its resources, and why diabetes drugs and devices aren’t first in line.
Sanofi attempts to woo diabetes stakeholders about inhaled insulin at the ADA Scientific Sessions.
Panelists at the ADA Scientific Sessions lament the commoditization of a life-saving drug.
A certified diabetes educator answers whether older insulin is still safe to use.
Jennifer Smith of Integrated Diabetes Services answers a question about generic insulin brands available at WalMart.
A study finds glyburide can lead to worse neonatal outcomes for babies of moms with gestational diabetes.
If approved, Novo Nordisk’s insulin might prove stiff competition to Sanofi’s dominance in the basal insulin marketplace.
A family’s grief leads to a bill that would allow pharmacists to dispense insulin without a current prescription to save lives.
Sanofi’s new basal insulin will not be discounted. Could the decision doom sales?
Three certified diabetes educators collaborate to find possible solutions.
We weigh in on whether this is covered under the Americans with Disabilities Act
Haramine also stabilizes blood sugar levels in mice.
Two new studies explore the connection between probiotics and insulin sensitivity.
A certified diabetes educator reminds us that even those well-versed in their diabetes care can make errors in insulin storage or injecting technique.
MIT researchers discuss the process of creating glucose-sensing insulin and whether if it will ever be available for people with diabetes.
There have been poor launch sales of the new inhalable insulin system. Can it rebound?
Regulators are requiring all multi-dose pens be labeled “For single patient use only”.